TABLE 1.

Demographics and clinical characteristics of patients with cUTI and risk factors for fluoroquinolone resistance in univariate model^a

Variable	Value for patients infected with:		OR	95% CI	P value
	FQ-NS bacteria (n = 54)	FQ-S bacteria (n = 184)
Median (IQR) age (yr)	69 (59–81)	65 (54–76)	1.18b	0.98–1.43	0.09
No. (%) of male subjects	21 (39)	55 (30)	1.49	0.79–2.94	0.22
No. (%) of subjects of white race	29 (53)	83 (45)	1.41	0.77–2.61	0.27
No. (%) of subjects with:
Diabetes mellitus	21 (39)	71 (39)	1.01	0.54–1.88	0.97
Cancer	13 (24)	33 (18)	1.45	0.68–2.96	0.32
Hospital-acquired infection	9 (17)	38 (21)	0.77	0.33–1.65	0.51
Recent hospitalizationc	25 (46)	61 (33)	1.74	0.93–3.22	0.08
Residence at a skilled nursing facility	10 (19)	18 (10)	2.10	0.88–4.79	0.09
Recent outpatient procedured	6 (11)	5 (3)	4.48	1.30–16.13	0.02
Prior fluoroquinolone use
None	21 (39)	171 (93)	1	Referent	Referent
Within 3 mo	18 (33)	6 (3)	24.43	9.18–73.91	<0.001
Within 3–12 mo	15 (28)	7 (4)	17.45	6.60–50.47	<0.001

^acUTI, complicated urinary tract infections; OR, odds ratio; CI, confidence interval; IQR, interquartile range.

^bPer decade.

^cWithin 3 months of infection.

^dWithin 1 month of infection.